Kikkoman Corporation
Kikkoman Corporation (KIKOY) Financial Performance & Income Statement Overview
Review Kikkoman Corporation (KIKOY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Kikkoman Corporation (KIKOY) Income Statement & Financial Overview
Explore comprehensive income reports for Kikkoman Corporation KIKOY, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $173.46B | $179.95B | $177.35B | $178.22B |
| Cost of Revenue | $117.70B | $118.96B | $116.73B | $116.35B |
| Gross Profit | $55.76B | $60.98B | $60.62B | $61.87B |
| Gross Profit Ratio | $0.32 | $0.34 | $0.34 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $41.54B | $40.55B | $39.91B | $39.96B |
| Operating Expenses | $41.54B | $41.13B | $39.91B | $40.39B |
| Total Costs & Expenses | $159.24B | $160.09B | $156.64B | $156.74B |
| Interest Income | $0.00 | $0.00 | $0.00 | $6.76B |
| Interest Expense | $0.00 | $0.00 | $0.00 | $3.67B |
| Depreciation & Amortization | $6.92B | $6.005B | $1.34B | $6.005B |
| EBITDA | $18.14B | $26.96B | $22.05B | $27.48B |
| EBITDA Ratio | $0.10 | $0.15 | $0.12 | $0.15 |
| Operating Income | $14.22B | $19.86B | $20.71B | $21.47B |
| Operating Income Ratio | $0.08 | $0.11 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | -$562.00M | $2.85B | $1.87B | $3.20B |
| Income Before Tax | $13.66B | $22.71B | $22.58B | $24.67B |
| Income Before Tax Ratio | $0.08 | $0.13 | $0.13 | $0.14 |
| Income Tax Expense | $3.24B | $6.01B | $5.84B | $6.48B |
| Net Income | $10.37B | $16.57B | $16.71B | $18.05B |
| Net Income Ratio | $0.06 | $0.09 | $0.09 | $0.10 |
| EPS | $11.02 | $17.45 | $17.52 | $18.97 |
| Diluted EPS | $11.02 | $17.49 | $17.47 | $18.97 |
| Weighted Avg Shares Outstanding | $940.72M | $947.83M | $953.80M | $951.47M |
| Weighted Avg Shares Outstanding (Diluted) | $940.72M | $947.83M | $956.67M | $951.47M |
Financial performance has remained strong, with revenue growing from $178.22B in Q1 2024 to $173.46B in Q4 2024. Gross profit continued to perform well, with margins at 32% in the latest quarter. Operating income reached $14.22B in Q4 2024, holding a steady 8% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $18.14B. Net income dropped to $10.37B, keeping EPS at $11.02. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan